Google TrendMAX CASTER (200+) — Moose Def. Max Caster At TNA Bound For Glory 2026
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Key GLP-1 Statistics &amp" (30 stories)

Top Headline Story

Key GLP-1 Statistics & Trends In 2026
Lead StoryForbesgeneral
Jun 4

Key GLP-1 Statistics & Trends In 2026

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5VaHpHUVcyZTU4SWI5STdvY0JfUnZTMkliYmJWaDNuUko2X081bHhMMWxic3NySUhMb0VjSzNmSnRtaFpRN2k1OVdDQnZCOHFQMUJuYWRtWUV3Y0FzXzlOb1IxX2d3Zi1sZ28w?oc=5" target="_blank">Key GLP-1 Statistics & Trends In 2026</a>  <font color="#6f6f6f">Forbes</font>

Real-time search volume
200+22m ago

max caster

Moose Def. Max Caster At TNA Bound For Glory 2026

200+22m ago

prince harry family photo story

Prince Harry Reveals the Photo He Took of Archie and Lilibet That ‘Fills My Heart’

500+32m ago

kelley knockel

1 dead, multiple injured after pair of motorcycle crashes involving deer in Iowa

200+32m ago

torino vs udinese

Torino vs Udinese: Italian Serie A stats & head-to-head

Search Results for "Key GLP-1 Statistics &amp"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
GLP-1 consumer trends in food, apparel and wellness
PwCgeneral

GLP-1 consumer trends in food, apparel and wellness

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPNllpOTNJYkctS3JwSmU4VUhKRmtYbjVGR0NOcFVGRUV1WEhqVHlNOWg1alMxTVZ0VkdsSm1NdGhIS2pPVVBKTmpBai1UdHprQjJFVFo4ems4cjdVNl9BcklkWW1ka0dySm1CTGFicndoNnpURldQWmsyNTBIUG9hX05IYmlCX2ZhUFRSaHBXdmNnZw?oc=5" target="_blank">GLP-1 consumer trends in food, apparel and wellness</a>  <font color="#6f6f6f">PwC</font>

GLP-1 Market Size, Share & Forecast 2036
Fact.MRmarkets

GLP-1 Market Size, Share & Forecast 2036

<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE5teXYtUk4xZXBpUVlKWmpFNndzeks3dVR2dVk4WmMxNWZHS1Z1UHd0MmRDd2dwOTJXUmhUZ3dmbjhOX0RQQ250MzdWLUZEMm1CaTZoSg?oc=5" target="_blank">GLP-1 Market Size, Share & Forecast 2036</a>  <font color="#6f6f6f">Fact.MR</font>

Obesity in retreat as GLP-1 use nearly quadruples: New data paints a different picture for manufacturers
BakeryAndSnacks.comtech

Obesity in retreat as GLP-1 use nearly quadruples: New data paints a different picture for manufacturers

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOcXJRUkp3ZXJyT05Yc0tJNlF1cHh4SV9lNjVvRHVfV0tLSWtLVmZYRXdwYjIwQ0RQZjlLYndwRl80WXlGc1BXVXJDeG1SaEZWTXB1UnRwdmRxR0hRX1NXQ0J0STVNSktpajRFejV1aHZTV0VYWTI2NG1YblNHb2xpN0V4ZmNvMUVIaG8tMlJiSlhSTTg1ek4wZ2hTcXRGSEZxeGtzWTZZV2xvR19pWHpBSThwYml3TE5pTTd1MVlIeU5uTzIwZmc?oc=5" target="_blank">Obesity in retreat as GLP-1 use nearly quadruples: New data paints a different picture for manufacturers</a>  <font color="#6f6f6f">BakeryAndSnacks.com</font>

Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies
Fierce Pharmatech

Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOX01TcEd4emp4eUN6UFAteWRVY190dDlNZU9TaWhvTEZ1RmtMZW1yRmV2dkVlRUFPTi14Qmp3LVBDOGZIeHNSd2MxSjdtemZiZWVTS21MbFZSQi1XY0M4MUtTT1hQTjZObzRrcDd3VzF6Ql9NbDJvMWxYSXlPNXdQWi13YzJyQVFVU2xpZkdtOXhlaGdMUzJ1SjJJRHo4d3dTdU1vVXVZREpwMzA4d0lfcXQxTlJxRzZWanczVW5xZzlrQQ?oc=5" target="_blank">Novo, Lilly tout respective early response and weight loss maintenance data as GLP-1 rivalry intensifies</a>  <font color="#6f6f6f">Fierce Pharma</font>

GLP-1 Therapies Silence Spontaneous Physical Activity
Neuroscience Newsgeneral

GLP-1 Therapies Silence Spontaneous Physical Activity

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBwOE10Yk1tSXNrRk1nMHF0alZMdXNMajR1YW1MUnk2ZVJMOUV1allZR1VPVWF2aVdNeWNFemRhTGd6NWNUQzBrM2JKbW91OXA0Qkhyb2tFdkRSeGRIaUtTSEpXVm54WmtQM3c?oc=5" target="_blank">GLP-1 Therapies Silence Spontaneous Physical Activity</a>  <font color="#6f6f6f">Neuroscience News</font>

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)
Seeking Alphageneral

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOGtFVmdFVXpzUkNHalpkQWxMNThzSlE2TU5TSTcxUGFTUl90UWw4TmZXN1VLR25fX3FibjlsVnVOS3NrRExFdHB6N1N6cFp2cGhaOC1EcXlMcWJTZUJXSWwtWW5CTWltNU15ZmRWams0OUhKMktZaGhfT2k1SUJlRnRLNFRrcTVZQ1d2Sk50MkFBMzYxSm9hbUdGSGUzNUVUN280dEdMM2xZNl9KaFRPdDcxRXBvVUJFX1ZiQ3M0Y3M?oc=5" target="_blank">Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)</a>  <font color="#6f6f6f">Seeking Alpha</font>

GLP-1 Hydration Products Market Outlook 2036 with Key Contributions from Smoothie King, Liquid I.V., Electrolit, Abbott, Nestlé Health Science, and ADM | Future Market Insights
Yahoo Financemarkets

GLP-1 Hydration Products Market Outlook 2036 with Key Contributions from Smoothie King, Liquid I.V., Electrolit, Abbott, Nestlé Health Science, and ADM | Future Market Insights

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPc21DN3k0N1ZMdE0wRExOWll5SlRERlgyN1JiV3Noc2tCMVJfd2xWdDBEYmpQdy1WTDBNTlhEaF9BaEZaZGoxbi04ejZfZDlMVDJIRHljM0s1VWxFZ3RFcUl2MFFMU1owWDlLem1hRzk5ek5tTnBGanB6VU9iSXZ3aDhlTVVMZXZJNXVlRWc4RU9USFJmMnZRMmNtd2swNEgzUFE?oc=5" target="_blank">GLP-1 Hydration Products Market Outlook 2036 with Key Contributions from Smoothie King, Liquid I.V., Electrolit, Abbott, Nestlé Health Science, and ADM | Future Market Insights</a>  <font color="#6f6f6f">Yahoo Finance</font>

Boehringer links dual agonist to 16.6% weight loss in phase 3, but leaves key questions unanswered
Fierce Biotechworld

Boehringer links dual agonist to 16.6% weight loss in phase 3, but leaves key questions unanswered

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOSzRxdm1JNEZNdWU1djBVMjRiLXE5a1I2SU5lT1UtN2dwSHFSMk9FMmlIdUhhNGVRV1Y1YVhTWFluLXFibVVhck1hTW5uSzVrMnB4MThQTVpxSlpfOG9LXzYxWjdXU1NrUDY4YllfYVV4Wm44WXlMWHh4bnhYTHlUamgyb0VZYUZDRldfZXJMcGVHb0NfTXZEdjFES2o0UTFZb2dhNHlxTm4wZFFGYk1LX29sa01aaU83VlFNcXhqOHY?oc=5" target="_blank">Boehringer links dual agonist to 16.6% weight loss in phase 3, but leaves key questions unanswered</a>  <font color="#6f6f6f">Fierce Biotech</font>

ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come
BioSpaceworld

ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxOTk54dFZoSlpTRVExeFBDM2ZTOXJyRThuaGU3WVNJbFZPMVZmazV3ZHJwT21Qa2x4azJzQW84QWVYZkd1Rm9uTDFEa3RkdjVtRng0UEdBbUloendyU0RaeV8xMmtZZUladkRxV0xSclZDa0QzUmo5cUpKSFBGeDUtWXlud3M5U0ZGSnYxUU5JY2VrY21NZXl2eUp3aEhMM19VR2pPd09tYjVFZjFMbDVOVWs4R0ZpU1hBVU9oci1kVkFvdF9WbmowMFhn?oc=5" target="_blank">ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come</a>  <font color="#6f6f6f">BioSpace</font>

GLP-1 Key Facts
National Academy of Medicinegeneral

GLP-1 Key Facts

<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBEUk8yaWNOWkU3NW9zOVNUZVBfVXc5ZFQzY05PbFlEeUlLNTI2S3o0TmJhRDktS3pEZTg1T3d0R0ZwSW5WVExVNzl5dENGTHRsb0MxVWJ4cmo?oc=5" target="_blank">GLP-1 Key Facts</a>  <font color="#6f6f6f">National Academy of Medicine</font>

Public Opinion on Prescription Drugs and Their Prices
KFFgeneral

Public Opinion on Prescription Drugs and Their Prices

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQV1U5LVppc0xqNzdzQW1pdGd0UGd6bkVqSGdIel9lZkx5SjE0QXlpUE5uWk1jaFRMbk9IdzZsbjNxNjd4eG5mdEpVeGVEUGhGbldoUXZaTDc3bGRXbkp5V0x3Tlh2RXBSNWtmek1BcWlPRnlyWC1DTGVoUDN6dWtiMkl5SlEwaXVoYUdHY190M2E?oc=5" target="_blank">Public Opinion on Prescription Drugs and Their Prices</a>  <font color="#6f6f6f">KFF</font>

1 in 8 Americans Now Use GLP-1 Drugs for Weight Loss
Statistageneral

1 in 8 Americans Now Use GLP-1 Drugs for Weight Loss

<a href="https://news.google.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?oc=5" target="_blank">1 in 8 Americans Now Use GLP-1 Drugs for Weight Loss</a>  <font color="#6f6f6f">Statista</font>

GLP-1 Receptor Agonists in Breast Cancer: 5 Key Clinical Takeaways
CancerNetworkgeneral

GLP-1 Receptor Agonists in Breast Cancer: 5 Key Clinical Takeaways

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOaXVna20wX0VzeHE2MzVoTnk2WGZpYkFoRHFVbVprSzVaUG9jcTdHTGdtNF9kYVI5Q3k5V2t2ekczVm9BX2I1cjFCMWFSSXFXN2JkOHFZNmZBUThDWHg3MFhxT3h4WklWU2tRSVFXYnZucTc5aVRBbjJGMkZwR1lueGZiVjc1WWJ0dlhJT1VSNjIzMW5rVVQtSHNHSkxmejFBOWc?oc=5" target="_blank">GLP-1 Receptor Agonists in Breast Cancer: 5 Key Clinical Takeaways</a>  <font color="#6f6f6f">CancerNetwork</font>

As demand for GLP-1 pills and shots surges, healthy habits are still key
www.ap.orgscience

As demand for GLP-1 pills and shots surges, healthy habits are still key

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQUWlKcDZOclY2Q2FxNkRWSTh4TFhUYlNCRUtEaHo0eG1aeUpaaTBDd3lhMEowT2pJZGdCUEZFMjRNM3VxdHd2ajZ2R1FSdHk5c2xKMXN4bVVSbjNxS245a3MxaG14V1lOb1dUOTBqb0dqV2VFX2lzQWZ5TEFlVzE4bGNsS2ZhbHhwV1NkWndqWEJ3MDlqTzdUcjdLTmttZlhzTElLVkN2cmZTak4xRTA4alBCbEZ3YnJ2MC1tUTlkWU4?oc=5" target="_blank">As demand for GLP-1 pills and shots surges, healthy habits are still key</a>  <font color="#6f6f6f">www.ap.org</font>

6 facts about obesity and weight loss drugs in the U.S.
Pew Research Centergeneral

6 facts about obesity and weight loss drugs in the U.S.

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPS2ExWUYyR05Iek5scDhCUkFkdnlWRTJ2UndUalBjSkkxNTNJaDNFRUswLUR4WkpleWtkSGxzXzFCUno1YWNmRHVGMzhScHpjaktGNXNNM2JQVUlkOFNRejJRSWZia08xNHh6U2x1QjdFTS01QzEtVW5KenktQXBjY05Dd1hUV2tDaFRfUG4yRzFFQWUzdnU4N0l1MDVKY0kzbTlhSExBME9WZw?oc=5" target="_blank">6 facts about obesity and weight loss drugs in the U.S.</a>  <font color="#6f6f6f">Pew Research Center</font>

WHO issues global guideline on the use of GLP-1 medicines in treating obesity
World Health Organization (WHO)general

WHO issues global guideline on the use of GLP-1 medicines in treating obesity

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPeTZxWWZXQmVISXhfeHZwRzFrbHo4M1ZlNXc0VzZkR0xfa05wZ0Y4RldxVUl4aENONWhRSC1IZEp0SEtmZ1F0NV9uQm42RHFCNjNkZ2cxTnpoNHdTR3hjZ2I1b1J6NVdPaHkwT2MyRnh4YkI5Y0xxSEdWODlIbk45SEtVN2hRTTA2N09weHcxcXBiV2dJQ3R6UkM2U1hpN3hma2ZuaXBkT3ktZThvdDJueG4yY2tBY3NKS3c?oc=5" target="_blank">WHO issues global guideline on the use of GLP-1 medicines in treating obesity</a>  <font color="#6f6f6f">World Health Organization (WHO)</font>

Who Is the GLP-1 Consumer? Data on 58,000 U.S. Adults
Morning Consultgeneral

Who Is the GLP-1 Consumer? Data on 58,000 U.S. Adults

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxPYjVxRlFCemRFQmw4MVZZemh1bXI0RjgtN3pvQzhfclgtZ0t0NGhEM2NnaGFZVkhHMGpyZDhuQkpKU01xRjVLY3RSWDBHNHlxZjlveDJPbWE2Zmp3SEJSdW1raWt3aUp3eGhhNlk5YTFHS3dQd1E3NWlyd2Nkc3otQkpn?oc=5" target="_blank">Who Is the GLP-1 Consumer? Data on 58,000 U.S. Adults</a>  <font color="#6f6f6f">Morning Consult</font>

Key Facts About Medicare Drug Price Negotiation
KFFgeneral

Key Facts About Medicare Drug Price Negotiation

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxQZnptdnZFdFZRVWhWVDdMVHNhY19EU1hya0stZ2dDbHZoZnJNWExlSGF5bks2ejVsRjU2LXZpTW1sb0wtWFBWTG4zVXowc0tvd0NvcTVibU12R1JFVGs3MUhYeG4wX3J0dmg0WjNfQTV6NkxBVHQxTndyTEdnRHctMklHUQ?oc=5" target="_blank">Key Facts About Medicare Drug Price Negotiation</a>  <font color="#6f6f6f">KFF</font>

What is the future of GLP-1 trends and its impact on business models
PwCgeneral

What is the future of GLP-1 trends and its impact on business models

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNM3Fva2lzY2F3WmhMbVhuRTZqSDBVZDQ2RWx3VG1RQWNoVTdiOVE4T0p1bHV0MGtqSzVDSFplWUZSQUNCamk0UVhKMXg0Zzh1UVcxYWNHOG1xNkhqQ0RHM2tjT3ZUNklMMGJOR2JHQ0gtc1pyUXBMaUpPREg2QzI3cVhIek4tZGw1dkxxUFNFeGZzSF9PRW01V29NZmRCejBjeEEtaw?oc=5" target="_blank">What is the future of GLP-1 trends and its impact on business models</a>  <font color="#6f6f6f">PwC</font>

Social media data helps AI flag potential risks of GLP-1 medications
MedicalNewsTodaytech

Social media data helps AI flag potential risks of GLP-1 medications

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPeS03UV9YSnRlVWRMcDc1NzJQMWs0NVZjdlJndWNsalBTQ19GR0dHMW1VSGJONW1scVBLRWpJTWIwNll6V0ZaMnpMazlnRnpjdm14WEYwUGdORml4UGlfbW91aTlqbGM4aGkwOVpLNUNsZE9hQVBxZnQwbzJ1dVQ0aUIxWEFUOXBpamdSTTZLaEl0NHQ3am9jWmdXOFhQYWpCd0tSWjlsY3BzbDgxeDA3TG9fODB5UQ?oc=5" target="_blank">Social media data helps AI flag potential risks of GLP-1 medications</a>  <font color="#6f6f6f">MedicalNewsToday</font>

ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS
AbbVie News Centergeneral

ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQeHFuamZWYmVzQks4aG12WHp4dldhM1V6dHdJQ2RvZWV2Mnhmal9wRk9UMm0wSjlNUFdEQUh5UzQteXRCUl9abUdOMU1KRFJpR3BEcW9pYkttNHk1WXlvR1JQQmM0d0ZZS29UOWk1Vi1vcXBxc1BtVzRPR1BNZnQ1UVNkcFRGQ0s3QVV6Rm9GVmZ4VkI2WEx3cklSRzNYUWlPaVdGYnlYOXNJUG9RYVpmTm1LeHVIaU5DV3FmUXpQWXFBZHFfRFZYN0xkTQ?oc=5" target="_blank">ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS</a>  <font color="#6f6f6f">AbbVie News Center</font>

KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs
KFFscience

KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNTVNOblNYMUZJOXRUcnBMUEl3UTJjMC05WUpFNzVoWVdmTi1GeXhuNFl4eUV3eGdWSzNSSTZobjY5T2IzcTd2SGxsWVdkTXVxUUdfQ0NsNVJ6T2MxQl9XUFkxblVSajV2cDAtSzZ0N0Q1WU55WUktNkpTZ01NMXVxQ1AyRVZxekJmaHJPSEhURWZNR1JCd0tLVS1LM0lHNUdsdjVGQ01pa3lUTlM5?oc=5" target="_blank">KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs</a>  <font color="#6f6f6f">KFF</font>

Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases
Naturegeneral

Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBocWdJdW1jUVhQUU5YUUxYOXZGQUZ0bWUzUWc5c1AzelA0clQ3UDloQWt0X2dlMGpWS2lyeUdWX2djUVIxYVRDRkpDYmZJUFJUWEJhNE9XUV8wMzBlVXQ4?oc=5" target="_blank">Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases</a>  <font color="#6f6f6f">Nature</font>

GLP-1 Therapies and Cancer Prevention: Metabolic Dysfunction as the Key Determinant
DocWireNewsworld

GLP-1 Therapies and Cancer Prevention: Metabolic Dysfunction as the Key Determinant

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNZ1lLMlFfc2drRzRLeURQYVdrbjJhdEpOWUtiNWdyNXBOZUZFb0I0WkFYRzlHSTJVZl9aUjBVaTRRd2Znc1FINkpQbjlPaWVTNV9XemE2TXVSRGxIaWZ0RkdHbVozSzFBS0RfN1hTazdocU9IV0VkZnhTYkhLdUhrT2NianpOc1NSUzVwcE1fcDhSbUk2ZDlOUHBaa1Fnc0lROHJpTU1TVHFFeFJ4VWQ5TFIzdkZGZw?oc=5" target="_blank">GLP-1 Therapies and Cancer Prevention: Metabolic Dysfunction as the Key Determinant</a>  <font color="#6f6f6f">DocWireNews</font>

GLP-1 Medications in Teens With Obesity Lack Long-term Data
Medscapegeneral

GLP-1 Medications in Teens With Obesity Lack Long-term Data

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQTTcwOHdwekhaX2ZrWVh2eUNIbFYwQlM5WFNpTGR4SEl2NkRuOFFIZ09ZZlFHeFZjZXliRHBGaHlldHg1NFZNaEFLaWR4MXM1QlJfN2FBRjRNcXYxLXp5a2o0dzMwMEFtcDVncEVGMnhzSWxjZWQ0TnRLYTdHOFJ3UVFzVXJxSFBDOERkcVlkOU5fSThnQVB6MXFyYlpvcjBOQ21ZVkZrd0JRVEUtTzI4?oc=5" target="_blank">GLP-1 Medications in Teens With Obesity Lack Long-term Data</a>  <font color="#6f6f6f">Medscape</font>

Do GLP-1 Drugs Protect the Heart, Kidneys and Liver Beyond Weight Loss?
University of Colorado Anschutzgeneral

Do GLP-1 Drugs Protect the Heart, Kidneys and Liver Beyond Weight Loss?

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxON2JFcHVkV1pUTHZ0S05oVEtDWTNOWDU1RDFaalJPaUdxMEMtdVBJaXgyREM1STd4VjJCQmZnUGtkTzNNU240cWg5N0g3cWxYUnlIajhSOURaVzhraUFhRUdpdjJXbVh4bDBZMHdvSkVDcG5BaF85S2I2WW9nVWlENG00eTdoNy1oZUctQmIyTnZvbkJKNVdsTXNsMzdNUdIBrgFBVV95cUxOdXJOejRld0pCOVFpOW9IU01tbGFCbzFUTk9iRGNuUU1PMXVZeXJGcUg0WEM5VFFOLXRDZjNKcnViZmtZU1lRY0MtdnZPWEdXNVQ5a2gxYURiX25PZ3pkTFdIY1ViU2JsVDh3WGU4VE1ncG5uUU5QZktJNUFLM1JteTJ3bHlpRTlCU3BIckFlMWFBRmFZaG9nUUg5VEZ2VGV4YUE4UWR6VjdwWU5Td2c?oc=5" target="_blank">Do GLP-1 Drugs Protect the Heart, Kidneys and Liver Beyond Weight Loss?</a>  <font color="#6f6f6f">University of Colorado Anschutz</font>

GLP-1 RA prescription trends: January 2018 – September 2025
Truvetageneral

GLP-1 RA prescription trends: January 2018 – September 2025

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPWDFPMmtsMnVLQkhYeVVJNlhQSXJUZDl2M3BCVlA2TVg4TVB1V3hSMGM3QTlwMHBlZUxFRGY5OC1FZ3BJYS1oLVhoUzFiOWhjdllHSDhZUkhPWHhrSXZYdVFCX0s4cXZPMXNWM0tscXhmTkd3U2tqNTZNdTJmTTY4VGFIeGhaeWJpVC1DVFdtYkViNndkRGdwUlRaUXotb2J0VHc?oc=5" target="_blank">GLP-1 RA prescription trends: January 2018 – September 2025</a>  <font color="#6f6f6f">Truveta</font>

Key Lessons for Ethical and Affordable Access to GLP-1 Drugs Like Ozempic and Wegovy
Penn LDIgeneral

Key Lessons for Ethical and Affordable Access to GLP-1 Drugs Like Ozempic and Wegovy

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNb2NKZjgxNGtidXJxMkpmbl92VnJDVUNXOFRpbU9FS0xURi1VMlNMVWhGdkNScWN1UFlySU96M2lvcEtkQkJDVERJRVVfUy1xaHBOU3RGbGg5M2ZVSXdacWtjeTBKaTdOeC1JQWMzaVl2eUlnRVdSWklTM21FYTFzV1BtRDk4MUdEMWtEcWhJNFJvSkp6X1d2ckRjWTFYd0QxbmhPV1VQWWE2cmVWTWNZeHRFOTFGeVBpVmNwazZnQ2FrYmM5T0ZXMDVKdnA3dw?oc=5" target="_blank">Key Lessons for Ethical and Affordable Access to GLP-1 Drugs Like Ozempic and Wegovy</a>  <font color="#6f6f6f">Penn LDI</font>

Employer Benefits and Social Stigma Drive GLP-1 Use Among US Workers, Survey Finds
AJMCgeneral

Employer Benefits and Social Stigma Drive GLP-1 Use Among US Workers, Survey Finds

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPUTcwR2ZvS3lfRWc2aTRaRDNIeEpvdzdzNGFPSFRYVHFSaTh2b0FQSk5hdHNFT2VKUWNlUFBLNy1jS0MzM3ljdm85WGJLN2pkUU1oTGFLVS1JX0ROUVdDeC1EYktMblVXODVZblRvbElJLTM2NGU4X1gzbERGUWN0Um5RYW1YdHR0eDZscVdGdDBFdHRMb2RQb0E5T01SSXlXRE03amVoNndnZ2c?oc=5" target="_blank">Employer Benefits and Social Stigma Drive GLP-1 Use Among US Workers, Survey Finds</a>  <font color="#6f6f6f">AJMC</font>

"Key GLP-1 Statistics &amp" — Live Google News Trends & Headlines